MA26792A1 - Composition comportant la sphingomyelinase alcaline a utiliser comme preparation dietetique , supplement alimentaire ou produit pharmaceutique. - Google Patents

Composition comportant la sphingomyelinase alcaline a utiliser comme preparation dietetique , supplement alimentaire ou produit pharmaceutique.

Info

Publication number: MA26792A1
Authority: MA; Morocco
Prior art keywords: composition; pharmaceutical product; food supplement; alkaline sphingomyelinase; dietetic
Prior art date: 1999-06-09

Application number

MA26417A

Other languages

English (en)

Inventor

Simone Claudio De

Original Assignee

Vsl Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-09

Filing date

2001-11-21

Publication date

2004-12-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA26792(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-11-21 Application filed by Vsl Pharma Ltd filed Critical Vsl Pharma Ltd

2004-12-20 Publication of MA26792A1 publication Critical patent/MA26792A1/fr

Links

102100036093 Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 Human genes 0.000 title abstract 2
101000876377 Homo sapiens Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 Proteins 0.000 title abstract 2
235000005911 diet Nutrition 0.000 title abstract 2
230000000378 dietary effect Effects 0.000 title abstract 2
239000000203 mixture Substances 0.000 title abstract 2
235000015872 dietary supplement Nutrition 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1
229940127557 pharmaceutical product Drugs 0.000 title 1
241000590002 Helicobacter pylori Species 0.000 abstract 1
208000035150 Hypercholesterolemia Diseases 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
229940037467 helicobacter pylori Drugs 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
210000000936 intestine Anatomy 0.000 abstract 1
235000016709 nutrition Nutrition 0.000 abstract 1
230000001575 pathological effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/04—Phosphoric diester hydrolases (3.1.4)
- C12Y301/04012—Sphingomyelin phosphodiesterase (3.1.4.12)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/195—Proteins from microorganisms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Microbiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nutrition Science (AREA)
Epidemiology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Obesity (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)

MA26417A 1999-06-09 2001-11-21 Composition comportant la sphingomyelinase alcaline a utiliser comme preparation dietetique , supplement alimentaire ou produit pharmaceutique. MA26792A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT1999RM000376A IT1311495B1 (it)	1999-06-09	1999-06-09	Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.

Publications (1)

Publication Number	Publication Date
MA26792A1 true MA26792A1 (fr)	2004-12-20

Family

ID=11406823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26417A MA26792A1 (fr)	1999-06-09	2001-11-21	Composition comportant la sphingomyelinase alcaline a utiliser comme preparation dietetique , supplement alimentaire ou produit pharmaceutique.

Country Status (34)

Country	Link
US (2)	US20020031507A1 (fr)
EP (1)	EP1181047B9 (fr)
JP (2)	JP4897167B2 (fr)
KR (1)	KR100812806B1 (fr)
CN (3)	CN101352234A (fr)
AR (1)	AR024564A1 (fr)
AT (1)	ATE237350T1 (fr)
AU (1)	AU778946B2 (fr)
BR (1)	BR0011447A (fr)
CA (1)	CA2376048C (fr)
CZ (1)	CZ296369B6 (fr)
DE (1)	DE60002194T3 (fr)
DK (1)	DK1181047T4 (fr)
DZ (1)	DZ3160A1 (fr)
EA (1)	EA005166B1 (fr)
EE (1)	EE05491B1 (fr)
EG (1)	EG24675A (fr)
ES (1)	ES2195902T5 (fr)
HK (1)	HK1046246A1 (fr)
HU (1)	HU228941B1 (fr)
IL (2)	IL146888A0 (fr)
IS (1)	IS2742B (fr)
IT (1)	IT1311495B1 (fr)
MA (1)	MA26792A1 (fr)
MX (1)	MXPA01012641A (fr)
NO (1)	NO327862B1 (fr)
PL (1)	PL214675B1 (fr)
PT (1)	PT1181047E (fr)
SI (1)	SI1181047T2 (fr)
SK (1)	SK285901B6 (fr)
TR (1)	TR200103566T2 (fr)
UA (1)	UA80799C2 (fr)
WO (1)	WO2000074712A2 (fr)
ZA (1)	ZA200200039B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1311495B1 (it) *	1999-06-09	2002-03-13	Mendes S U R L	Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.
IE20011100A1 (en) *	2001-12-21	2003-07-09	Vsl Pharma Ltd	Analytical Method for Detecting Alkaline Sphingomyelinase and Kit for Use in Such Method
US9980988B2 (en)	2002-03-13	2018-05-29	Kibow Biotech, Inc.	Compositions and methods for augmenting kidney function
US20050074442A1 (en) *	2002-03-13	2005-04-07	Natarajan Ranganathan	Compositions and methods for augmenting kidney function
US9655932B2 (en)	2002-03-13	2017-05-23	Kibow Biotech, Inc.	Composition and method for preventing or treating gout or hyperuricemia
US11103542B2 (en)	2002-03-13	2021-08-31	Kibow Biotech, Inc.	Composition and method for maintaining healthy kidney function
KR100568036B1 (ko) *	2004-08-12	2006-04-07	하남주	장기능 활성화 및 면역기능 강화작용을 하는비피도박테리움 균주 및 이를 함유하는 생균제제
KR100610379B1 (ko) *	2004-08-26	2006-08-10	하남주	면역 증강 활성을 가지는 신규 유산균
TW200837194A (en) *	2007-03-06	2008-09-16	Microbio Company Ltd Taiwan	Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof
KR100868777B1 (ko) *	2007-03-15	2008-11-17	재단법인서울대학교산학협력재단	Ｒｓ３ 유형의 저항 전분에 대해 분해능이 있는비피도박테리움 아도레스센티스를 유효성분으로 함유하는것을 특징으로 하는 식품 조성물
DK2270133T3 (en)	2008-04-22	2015-09-07	Corporación Alimentaria Peñasanta Capsa	Method of obtaining a new strain of Bifidobacterium bidifum with effect against infection with Helicobacter pylori
ES2395529B1 (es)	2011-06-08	2014-04-11	Pri, S.A.	Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
KR101364695B1 (ko) *	2011-06-29	2014-02-19	가천대학교 산학협력단	헬리코박터 파이로리의 생육을 저해하는 타락 유래 젖산균
MX2015005165A (es) *	2012-10-25	2015-10-29	Gervais Danone Sa	Cepas de streptococcus thermophilus para tratar infeccion por helicobacter pylori.
KR101479818B1 (ko) *	2012-12-17	2015-01-26	주식회사 알엔에이	유산균 파쇄물의 제조방법
TW201630596A (zh) *	2015-01-06	2016-09-01	Meiji Co Ltd	鞘脂質吸收促進劑
WO2017179602A1 (fr) *	2016-04-13	2017-10-19	株式会社明治	Composition d'amélioration de la fonction cérébrale pour nouveau-nés
US11179426B2 (en)	2016-12-29	2021-11-23	Kibow Biotech, Inc.	Composition and method for maintaining healthy kidney function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS55120787A (en) *	1979-03-09	1980-09-17	Teruhiko Beppu	Preparation of sphingomyelinase
JPS60221084A (ja) *	1984-04-18	1985-11-05	Chiyoda Chem Eng & Constr Co Ltd	スフインゴミエリナ−ゼの製造法
US5716615A (en) *	1992-02-10	1998-02-10	Renata Maria Anna Cavaliere Vesely	Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
JP2676484B2 (ja) *	1994-03-28	1997-11-17	熊本県	ヨーグルト様乳酸発酵食品の製造方法
JP3122333B2 (ja) *	1995-02-28	2001-01-09	株式会社薬理学中央研究所	赤血球を原料とするスフィンゴミエリンおよびセラミドの新規製造方法とセラミド配合治療剤又は化粧品
JP4021951B2 (ja) *	1996-03-01	2007-12-12	わかもと製薬株式会社	乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品
JP3530674B2 (ja) *	1996-03-04	2004-05-24	明治乳業株式会社	変異原性物質吸収阻害性食品
IT1288119B1 (it) *	1996-06-28	1998-09-10	Renata Maria Anna Ve Cavaliere	Composizioni dietetiche da utilizzare nell'alimentazione per via enterica
IT1296148B1 (it) *	1996-11-22	1999-06-09	Renata Maria Anna Ve Cavaliere	Uso di batteri lattici per accrescere il livello delle ceramidi della pelle e delle mucose, e composizioni dermatologiche e cosmetiche atte
JP3400282B2 (ja) *	1997-02-21	2003-04-28	株式会社ヤクルト本社	脂質代謝改善剤およびそれを含有する食品
IT1298918B1 (it) *	1998-02-20	2000-02-07	Mendes Srl	Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1311495B1 (it) *	1999-06-09	2002-03-13	Mendes S U R L	Composizione comprendente sfingomielinasi alcalina, utilizzabile qualeprodotto dietetico, integratore alimentare o medicamento.

1999
- 1999-06-09 IT IT1999RM000376A patent/IT1311495B1/it active
2000
- 2000-06-07 HK HK02107847.8A patent/HK1046246A1/zh unknown
- 2000-06-07 TR TR2001/03566T patent/TR200103566T2/xx unknown
- 2000-06-07 CN CNA2008100823554A patent/CN101352234A/zh active Pending
- 2000-06-07 KR KR1020017015723A patent/KR100812806B1/ko not_active Expired - Fee Related
- 2000-06-07 ES ES00940741T patent/ES2195902T5/es not_active Expired - Lifetime
- 2000-06-07 PT PT00940741T patent/PT1181047E/pt unknown
- 2000-06-07 EA EA200200019A patent/EA005166B1/ru not_active IP Right Cessation
- 2000-06-07 DE DE60002194T patent/DE60002194T3/de not_active Expired - Lifetime
- 2000-06-07 PL PL364729A patent/PL214675B1/pl unknown
- 2000-06-07 SK SK1716-2001A patent/SK285901B6/sk not_active IP Right Cessation
- 2000-06-07 EP EP00940741A patent/EP1181047B9/fr not_active Expired - Lifetime
- 2000-06-07 CA CA2376048A patent/CA2376048C/fr not_active Expired - Fee Related
- 2000-06-07 EG EG2000060749A patent/EG24675A/xx active
- 2000-06-07 DK DK00940741.2T patent/DK1181047T4/da active
- 2000-06-07 AT AT00940741T patent/ATE237350T1/de active
- 2000-06-07 JP JP2001501246A patent/JP4897167B2/ja not_active Expired - Fee Related
- 2000-06-07 SI SI200030104T patent/SI1181047T2/sl unknown
- 2000-06-07 AR ARP000102836A patent/AR024564A1/es not_active Application Discontinuation
- 2000-06-07 WO PCT/IT2000/000230 patent/WO2000074712A2/fr not_active Ceased
- 2000-06-07 CN CN00808645A patent/CN1354672A/zh active Pending
- 2000-06-07 EE EEP200100661A patent/EE05491B1/xx not_active IP Right Cessation
- 2000-06-07 IL IL14688800A patent/IL146888A0/xx unknown
- 2000-06-07 DZ DZ003160A patent/DZ3160A1/fr active
- 2000-06-07 CZ CZ20014219A patent/CZ296369B6/cs not_active IP Right Cessation
- 2000-06-07 BR BR0011447-2A patent/BR0011447A/pt not_active Application Discontinuation
- 2000-06-07 CN CN200910129862.3A patent/CN101695374B/zh not_active Expired - Fee Related
- 2000-06-07 AU AU55639/00A patent/AU778946B2/en not_active Ceased
- 2000-06-07 HU HU0201631A patent/HU228941B1/hu not_active IP Right Cessation
- 2000-06-07 MX MXPA01012641A patent/MXPA01012641A/es active IP Right Grant
- 2000-07-06 UA UA2002010182A patent/UA80799C2/uk unknown
2001
- 2001-09-24 US US09/960,652 patent/US20020031507A1/en not_active Abandoned
- 2001-11-21 MA MA26417A patent/MA26792A1/fr unknown
- 2001-11-27 IS IS6178A patent/IS2742B/is unknown
- 2001-12-03 IL IL146888A patent/IL146888A/en not_active IP Right Cessation
- 2001-12-07 NO NO20016004A patent/NO327862B1/no not_active IP Right Cessation
2002
- 2002-01-07 ZA ZA200200039A patent/ZA200200039B/xx unknown
2004
- 2004-10-15 US US10/964,770 patent/US20050084486A1/en not_active Abandoned
2011
- 2011-10-13 JP JP2011226106A patent/JP2012040015A/ja active Pending

Also Published As

Publication number	Publication date
IL146888A (en)	2012-02-29
NO327862B1 (no)	2009-10-05
CN1354672A (zh)	2002-06-19
DK1181047T4 (da)	2010-03-15
CN101695374A (zh)	2010-04-21
CA2376048C (fr)	2014-12-09
SI1181047T1 (en)	2003-10-31
EG24675A (en)	2010-04-27
NO20016004D0 (no)	2001-12-07
KR20020016826A (ko)	2002-03-06
JP4897167B2 (ja)	2012-03-14
CA2376048A1 (fr)	2000-12-14
CZ296369B6 (cs)	2006-02-15
EP1181047A2 (fr)	2002-02-27
PT1181047E (pt)	2003-09-30
EE200100661A (et)	2003-04-15
HK1046246A1 (zh)	2003-01-03
ZA200200039B (en)	2002-12-24
NO20016004L (no)	2002-02-06
PL214675B1 (pl)	2013-09-30
ITRM990376A1 (it)	2000-12-09
JP2003501399A (ja)	2003-01-14
IS6178A (is)	2001-11-27
ES2195902T9 (es)	2011-03-01
EE05491B1 (et)	2011-12-15
EP1181047B1 (fr)	2003-04-16
EP1181047B2 (fr)	2009-10-28
US20020031507A1 (en)	2002-03-14
SK17162001A3 (sk)	2002-03-05
MXPA01012641A (es)	2004-03-19
WO2000074712A3 (fr)	2001-05-03
BR0011447A (pt)	2002-03-19
HUP0201631A3 (en)	2006-02-28
ITRM990376A0 (it)	1999-06-09
DE60002194T3 (de)	2010-02-25
HUP0201631A2 (hu)	2005-12-28
IT1311495B1 (it)	2002-03-13
ES2195902T5 (es)	2010-02-18
AR024564A1 (es)	2002-10-16
CN101352234A (zh)	2009-01-28
KR100812806B1 (ko)	2008-03-12
IS2742B (is)	2011-06-15
WO2000074712A2 (fr)	2000-12-14
EA005166B1 (ru)	2004-12-30
DK1181047T3 (da)	2003-08-11
DE60002194T2 (de)	2004-01-29
ES2195902T3 (es)	2003-12-16
SK285901B6 (sk)	2007-10-04
AU778946B2 (en)	2004-12-23
DZ3160A1 (fr)	2000-12-14
SI1181047T2 (sl)	2010-02-26
EA200200019A1 (ru)	2002-06-27
CZ20014219A3 (cs)	2002-04-17
PL364729A1 (en)	2004-12-13
JP2012040015A (ja)	2012-03-01
US20050084486A1 (en)	2005-04-21
TR200103566T2 (tr)	2002-05-21
AU5563900A (en)	2000-12-28
UA80799C2 (uk)	2007-11-12
IL146888A0 (en)	2002-08-14
DE60002194D1 (de)	2003-05-22
ATE237350T1 (de)	2003-05-15
CN101695374B (zh)	2015-08-19
HU228941B1 (en)	2013-07-29
EP1181047B9 (fr)	2010-08-25

Publication	Publication Date	Title
MXPA01012641A (es)	2004-03-19	Composicion que comprende esfingomielinasa alcalina para uso como una preparacion dietetica, suplemento alimenticio o producto farmaceutico.
WO2002007533A3 (fr)	2002-04-11	Composition nutritionnelle
TR200100610T2 (tr)	2001-07-23	Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
BR0313185A (pt)	2005-06-21	Probióticos para funções neuromusculares intestinais
BRPI0016231B8 (pt)	2021-05-25	composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo
EP1334728A3 (fr)	2003-09-03	Agents Antithrombotiques
DE69836822D1 (de)	2007-02-15	Verfahren zur Behandlung von Kapseln und trockenen gepulverten pharmazeutischen Formulierungen
WO2002056708A3 (fr)	2002-11-07	Preparation destinee a ameliorer l'assimilation des aliments
IL161995A (en)	2010-11-30	Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
DE60012301D1 (de)	2004-08-26	Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
JPH0657659B2 (ja)	1994-08-03	消化管にて種々のレベルで消化促進剤として作用する酵素組成物
CA2335308A1 (fr)	1999-12-23	Remede contre les boules de poils contenant une protease et utilisation de celui-ci
JP6222663B2 (ja)	2017-11-01	筋委縮抑制剤
DE60008276D1 (de)	2004-03-18	Magensaftresistente tablette für nahrung, diät und therapie
DE60019784D1 (de)	2005-06-02	Faserige lipo-ernährungskomplexe und diese enthaltende zusammensetzungen
AU2001282730A1 (en)	2002-02-25	Seal-oil-based pharmaceutical, cosmetic, dermo-cosmetic, hygiene, alimentary andpara-alimentary (food-supplements) products; their methods of preparation; thei r uses as preventive and/or as therapeutic agents
RU2002112886A (ru)	2003-11-20	Штамм Bifidobacterium bifidum 792, используемый для получения кисломолочных, ферментированных и неферментированных пищевых продуктов, заквасок, гигиенических и косметических средств, биологически активных добавок и бактерийных препаратов
TNSN99212A1 (fr)	2005-11-10	Composition antioxydante et preventive contre les anomalies thrombotiques et atherosclerotiques, comportant un carnitine et un flavonoide
RU96112884A (ru)	1998-10-20	Продукт творожный "александра"
ATE285757T1 (de)	2005-01-15	Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
WO2000024266A3 (fr)	2000-07-13	Compositions a base de soja et d'immunoglobulines
RU98105720A (ru)	1999-12-20	Биологически активная добавка для лечебных и косметических средств
EP1595879A3 (fr)	2010-01-27	Composés de benzimidazole substitués par un alkoxy, préparations pharmaceutiques contenant ces derniers, et procédés d'utilisation
KR19980076790A (ko)	1998-11-16	건강기능 식품이 첨가된 조미료
JP3660435B2 (ja)	2005-06-15	ニンニク臭の低減されたニンニク食品とその製造方法